BioCentury
ARTICLE | Clinical News

PPL-100: Phase I start

November 21, 2005 8:00 AM UTC

PBP will begin by year end a placebo-controlled, dose-escalation, Canadian Phase I study in 48 healthy male volunteers. Subjects will receive PPl-100 at 100, 300, 600, 1,200 or 2,400 mg with and witho...